| |
Last updated: April 24, 2008 |
| |
* Selected talks |
| |
MONDAY MAY 19, 2008 |
| |
8.00-9.15 |
Registration |
|
| |
Opening – Chair: Simon Wain-Hobson |
9.20-9.45 am |
| |
9.20 |
Alice Dautry, President, Institut Pasteur, France |
|
| |
9.25 |
Roselyne Bachelot-Narquin, French Minister of Health |
|
| |
9.25 |
Jean-François Delfraissy, Director, ANRS, Paris, France |
|
| |
|
| |
Early Days |
9.45-10.55 am |
| |
9.45 |
Luc Montagnier, UNESCO, Paris, France
HIV-AIDS: past and future |
|
| 10.20 |
Robert C. Gallo, Institute of Human Virology, Baltimore, USA
Some perspectives on HIV/AIDS research from the past and on HIV vaccine development for the future |
| |
|
| |
10.55 |
Coffee break |
|
| |
|
| |
The Virus - Chair: Ronald C. Desrosiers |
11.30-12.55 pm |
| |
11.30 |
Wesley Sundquist, University of Utah, Salt Lake City, USA
The biochemistry of HIV budding |
|
| |
11.55 |
Peter D. Kwong, Vaccine Research Center, Bethesda, USA
HIV-1 gp120, X-ray crystallography and vaccine design |
|
| |
12.20
|
Olivier Schwartz, Institut Pasteur, France
HIV, immunological and virological synapses |
|
| |
12.45 |
Timothy Hanley, Boston University School of Medicine, Boston, USA
Nuclear receptor signalling represses HIV-1 infection of and transmission by dendritic cells |
| |
|
| |
12.55 |
Lunch |
|
| |
|
| |
Restrictions Systems - Chair: Michael Malim |
2.30-4.00 pm |
| |
2.30 |
Monsef Benkirane, Human Genetic Institute, Montpellier, France
Interplay between HIV-1 replication and RNAi effectors |
|
| |
2.55 |
Thomas J. Hope, Northwestern University, Chicago, USA
Visualizing TRIM5α interactions with HIV-1 during restriction |
|
| |
3.20
|
Michael Malim, King's College, London, UK
APOBEC proteins and intrinsic resistance to HIV infection |
|
| |
3.45 |
Julia Friedman, Case Western Reserve University, Cleveland, USA
Epigenetic shutdown of HIV transcription drives entry of HIV into latency and controls viral reactivation |
| |
|
| |
4.00 |
Coffee break |
|
| |
|
| |
SIVs - Chair: Ronald C. Desrosiers |
4.30-6.00 pm |
| |
4.30 |
Martine Peeters, IRD, Montpellier, France
Diversity of primate lentiviruses and origin of HIV |
|
| |
4.55 |
Ronald C. Desrosiers, Harvard Medical School, Southborough, USA
Alternative vaccine approaches for the prevention of HIV infection |
|
| |
5.20 |
*Rita Tendeiro, Instituto de Medicina Molecular, Lisboa, Portugal
T-cell activation in HIV-2 infected individuals: effects of viremia and ART |
|
| |
5.30 |
Françoise Barré-Sinoussi, Institut Pasteur, Paris, France
HIV/AIDS pathogenesis: to fight or to tolerate the enemy? |
|
| |
|
| |
6.00 |
Poster Session 1 and Cocktails |
|
| |
|
| |
Tuesday May 20, 2008 |
| |
8.30 |
Welcome desk |
|
| |
Immunopathogenesis - Chair: Françoise Barré-Sinoussi |
9.00-11.05 am |
| |
9.00
|
Anthony S. Fauci, NIAID, NIH, Bethesda, USA
A newly discovered receptor for HIV |
|
| |
9.25
|
Daniel Douek, Vaccine Research Center, Bethesda, USA
HIV disease progression: immune activation, microbes and a leaky gut |
|
| |
9.55 |
Richard A. Koup, Vaccine Research Center, Bethesda, USA
Impact of different T cell functions in the control of HIV and opportunistic pathogens |
|
| |
10.20 |
Ashley Haase, University of Minnesota, Minneapolis, USA
The critical fast stage of the slow infections lentiviruses cause |
|
| |
10.45
|
*Anna Haas, Institute of Microbiology, Zurich, Switzerland
HIV-1 rebound affects CD4 T cell responses with specificities for persistent viral antigens |
| |
10.55 |
*Petronela Ancuta, University of Montreal, Montreal, Quebec, Canada
CCR6 identifies two memory CD4+ T cell subsets highly permissive to HIV infection |
|
| |
|
| |
11.05 |
Coffee break |
|
| |
|
| |
Immune Responses - Chair: Daniel Douek |
11.30-1.10 pm |
| |
11.30 |
Dennis R. Burton, The Scripps Research Institute, La Jolla, USA
Neutralizing antibodies and an HIV vaccine |
|
| |
11.55 |
Alexandra Trkola, University Hospital Zurich, Switzerland
Fighting HIV without (yet) winning the battle: antibodies and their role in immunity to HIV |
|
|
| |
12.20 |
Andrew J. McMichael, Weatherall Institute of Molecular Medicine, Oxford, UK
Early events in HIV infection |
|
| |
12.45 |
Bruce D. Walker, Partners AIDS Research Center, Charleston, USA
Durable control of HIV replication |
|
| |
|
| |
1.10 |
Lunch |
|
| |
|
| |
Host Genetics - Chair: Andrew J. McMichael |
2.40-4.30 pm |
| |
2.40 |
Mary Carrington, NCI, Frederick, USA
The complex influence of HLA class I and KIR on HIV-1 disease |
|
| |
3.05 |
Sunil K. Ahuja, University of Texas Health Medical Center, San Antonio, USA
From bench to bedside to populations: Translation of CCL3L1-CCR5 genetics for prevention and management of HIV-AIDS |
| |
3.30 |
Amalio Telenti, Institute for Microbiology, Lausanne, Switzerland
Host genomics and evolutionary genomics in HIV-1 |
|
| |
3.55 |
*Nadine Gehre, University Hospital Zurich, Zurich, Switzerland
Identification of host factors critical for the host’s defence against HIV |
|
| |
4.05 |
Simon Wain-Hobson, Institut Pasteur, Paris, France
Next slide please: a vertiginous 25 years’ research |
|
| |
|
| |
4.30 |
Coffee break and Poster Session 2 |
|
| |
|
| |
6.15 |
Departure for the gala dinner |
|
| |
|
| |
wednesday may 21, 2008 |
| |
8.30 |
Welcome desk |
|
| |
Vaccines - Chair: Gary Nabel |
9.00-10.30 am |
| |
9.00
|
Gary Nabel, Vaccine Research Center, Bethesda, USA
AIDS vaccines at a crossroad |
|
| |
9.20 |
Brigitte Autran, Hôpital La Pitié Salpetrière, Paris, France
Therapeutic immunization against HIV: where are we now? |
|
| |
9.45 |
Pierre Charneau, Institut Pasteur, Paris, France
From HIV-1 genome nuclear import, to lentiviral vectors to a therapeutic vaccine against AIDS |
| |
10.10 |
*Anders Fomsgaard, Statens Serum Institut, Copenhagen, Denmark
Dendritic cell vaccination with 7 novel subdominant HIV-1 CTL epitopes induces de novo T-cell responses |
| |
10.20 |
*Marie-Claire Gauduin, Southwest Foundation for Biomedical Research, San Antonio, USA
Mucosal immune responses induced by DNA/MVA and live attenuated SIV vaccine |
| |
|
| |
10.30 |
Coffee break |
|
| |
|
| |
The Bigger Picture - Chair: Jean-François Delfraissy |
11.00-12.20 am |
| |
11.10
|
Michel D. Kazatchkine, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland
Access to treatment in the developing world: a new era |
| |
11.35
|
Malegapuru W. Makgoba, University of KwaZulu-Natal, KwaZulu-Natal, South Africa
27 years of responding to AIDS… the ‘picture’ onwards |
|
| |
12.00 |
Peter Hale, GTZ/German Technical Cooperation
The research outlook for the next 25 years: The big picture |
|
| |
|
| |
Summing up |
12.25-1.00 pm |
| |
12.25 |
Robin A. Weiss, University College, London, UK
25 years already |
|
| |
|
| |
1.00 |
Lunch and departure |
|
